CN Patent

CN112451477A — 包含脱水山梨糖醇酯的药物组合物

Assigned to Alkermes Pharma Ireland Ltd · Expires 2021-03-09 · 5y expired

What this patent protects

本发明涉及一种药物组合物，其包含对抗精神病药物的递送有用的羧酸脱水山梨糖醇酯。

USPTO Abstract

本发明涉及一种药物组合物，其包含对抗精神病药物的递送有用的羧酸脱水山梨糖醇酯。

Drugs covered by this patent

Patent Metadata

Patent number
CN112451477A
Jurisdiction
CN
Classification
—
Expires
2021-03-09
Drug substance claim
No
Drug product claim
No
Assignee
Alkermes Pharma Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.